papillary renal cell carcinoma
Showing 1 - 12 of 12
Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)
Not yet recruiting
- Papillary Renal Cell Carcinoma
- Pembrolizumab
- Placebo
- (no location specified)
Nov 24, 2023
Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,
Recruiting
- Advanced Renal Cell Carcinoma
- +8 more
- Cabozantinib S-malate
- +3 more
-
Birmingham, Alabama
- +35 more
Jan 24, 2023
Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)
Recruiting
- Kidney Cancer
- +11 more
- 13C-Glucose
- +4 more
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 1, 2022
Study of Kidney Tumors in Younger Patients
Recruiting
- Adult Cystic Nephroma
- +24 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +247 more
Sep 2, 2022
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma Trial in Puerto Rico, United States
Recruiting
- Bladder Adenocarcinoma
- +45 more
- Cabozantinib S-malate
- +2 more
-
Birmingham, Alabama
- +563 more
Aug 24, 2022
Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma
Recruiting
- Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
- +6 more
-
Basking Ridge, New Jersey
- +6 more
Feb 2, 2022
Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los
Recruiting
- Clear Cell Papillary Renal Neoplasm
- +10 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 25, 2021
Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney Trial in Worldwide (drug,
Completed
- Childhood Renal Cell Carcinoma
- +12 more
- Doxorubicin Hydrochloride
- +9 more
-
Birmingham, Alabama
- +186 more
Jun 22, 2017
Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in Boston, Philadelphia,
Completed
- Chromophobe Renal Cell Carcinoma
- +5 more
- Bevacizumab
- +3 more
-
Boston, Massachusetts
- +4 more
Jan 6, 2015
Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Recurrent Renal Cell Cancer Trial in Durham (drug, biological,
Terminated
- Clear Cell Renal Cell Carcinoma
- +4 more
- sorafenib tosylate
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jul 1, 2013